Lisa Gill
Stock Analyst at JP Morgan
(3.45)
# 959
Out of 5,005 analysts
128
Total ratings
51.16%
Success rate
4.43%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MCK McKesson | Maintains: Overweight | $821 → $853 | $738.06 | +15.57% | 14 | Sep 26, 2025 | |
AVAH Aveanna Healthcare Holdings | Upgrades: Neutral | $6 → $10 | $8.63 | +15.87% | 3 | Sep 18, 2025 | |
OMI Owens & Minor | Maintains: Underweight | $7 → $6 | $4.76 | +26.05% | 5 | Aug 27, 2025 | |
UNH UnitedHealth Group | Maintains: Overweight | $418 → $310 | $360.20 | -13.94% | 9 | Aug 6, 2025 | |
ELV Elevance Health | Maintains: Overweight | $472 → $384 | $350.50 | +9.56% | 5 | Jul 22, 2025 | |
PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $24.09 | +32.84% | 5 | May 28, 2025 | |
DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $179.33 | +5.95% | 3 | May 6, 2025 | |
CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $20.75 | +44.58% | 2 | Mar 19, 2025 | |
OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $27.50 | +49.09% | 4 | Mar 6, 2025 | |
ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $16.62 | +2.29% | 4 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $283.72 | -9.77% | 6 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $81 | $77.49 | +4.53% | 5 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $142 → $145 | $154.46 | -6.12% | 6 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $301 | $302.76 | -0.58% | 2 | Jan 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $13.69 | +31.48% | 2 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $5.01 | -0.20% | 4 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $21.15 | +32.39% | 4 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $9.01 | -0.11% | 9 | Aug 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $311.00 | +40.84% | 13 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $14.02 | +28.39% | 1 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $201.97 | +95.57% | 2 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $276.94 | -12.26% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $207.24 | -10.25% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $203.00 | -31.03% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $429.54 | -22.71% | 3 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.53 | +120.75% | 1 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.13 | +696.46% | 3 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $5.51 | +45.19% | 4 | Nov 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $67.03 | +23.83% | 1 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $38.70 | +153.23% | 1 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $27.90 | - | 4 | Dec 19, 2017 |
McKesson
Sep 26, 2025
Maintains: Overweight
Price Target: $821 → $853
Current: $738.06
Upside: +15.57%
Aveanna Healthcare Holdings
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $8.63
Upside: +15.87%
Owens & Minor
Aug 27, 2025
Maintains: Underweight
Price Target: $7 → $6
Current: $4.76
Upside: +26.05%
UnitedHealth Group
Aug 6, 2025
Maintains: Overweight
Price Target: $418 → $310
Current: $360.20
Upside: -13.94%
Elevance Health
Jul 22, 2025
Maintains: Overweight
Price Target: $472 → $384
Current: $350.50
Upside: +9.56%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $24.09
Upside: +32.84%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $179.33
Upside: +5.95%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $20.75
Upside: +44.58%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $27.50
Upside: +49.09%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $16.62
Upside: +2.29%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $283.72
Upside: -9.77%
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $77.49
Upside: +4.53%
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $154.46
Upside: -6.12%
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $302.76
Upside: -0.58%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $13.69
Upside: +31.48%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $5.01
Upside: -0.20%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.15
Upside: +32.39%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $9.01
Upside: -0.11%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $311.00
Upside: +40.84%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $14.02
Upside: +28.39%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $201.97
Upside: +95.57%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $276.94
Upside: -12.26%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $207.24
Upside: -10.25%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $203.00
Upside: -31.03%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $429.54
Upside: -22.71%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.53
Upside: +120.75%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.13
Upside: +696.46%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $5.51
Upside: +45.19%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $67.03
Upside: +23.83%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $38.70
Upside: +153.23%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $27.90
Upside: -